TITLE

Were Mucinex's Sales Goosed by FDA Lobbying?

AUTHOR(S)
Edwards, Jim
PUB. DATE
April 2007
SOURCE
Brandweek;4/9/2007, Vol. 48 Issue 15, p7
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article examines whether the success of Adams Respiratory Therapeutics' Mucinex is attributed to a popular advertising campaign or the company's ties with federal regulators. The article explains that Mucinex has become one of the leaders in the over-the-counter drug industry, which the company asserts is due to its marketing campaign featuring an animated green blob named "Mr. Mucus." Analysts have noted that the success may actually be due to the company's lobbying of federal regulators.
ACCESSION #
24654851

 

Related Articles

  • UCB SELLS OTC DELSYM TO ADAMS RESPIRATORY THERAPEUTICS.  // Worldwide Biotech;Jul2006, Vol. 18 Issue 7, p3 

    Reports on the decision of UCB SA to sell Delsym, an over-the-counter drug, to Adams Respiratory Therapeutics Inc. Terms of the agreement; Use of Delsym as a cough medication in the U.S.; Background on the operations of UCB.

  • REPORTERS Notebook.  // Drug Store News;4/23/2007, Vol. 29 Issue 6, p50 

    The article reports developments in the pharmaceutical industry in the U.S. Nine new over-the-counter products it intends to launch in early fiscal 2008 was launched by Adams Respiratory Therapeutics. Bayer Nutritional Science line, a new line of nutritional supplements was introduced by Bayer...

  • Sales speak volumes for silent switch.  // Drug Store News;4/5/2004, Vol. 26 Issue 5, p17 

    Reports on the sales performance of Mucinex, an over-the-counter (OTC) cough expectorant brand of Adams Respiratory Therapeutics, for the period ending December 28, 2003. Approval from the U.S. Food and Drug Administration for Adams Respiratory Therapeutics to market an OTC cough expectorant;...

  • REPORTER'S NOTEBOOK.  // Drug Store News;3/6/2006, Vol. 28 Issue 3, p45 

    The article reports on developments related to the pharmaceutical industry in the U.S. Perrigo Co. has received final approval to begin marketing over-the-counter nicotine polarcrilex lozenges. Adams Respiratory Therapeutics announced its plans to enter the pediatric market. Quigley Corp....

  • OTC pharmaceuticals. Mehegan, Sean // MediaWeek;05/12/97, Vol. 7 Issue 19, Adweek p10 

    Highlights marketing strategies within the over-the-counter pharmaceutical industry of the United States for 1997. Competition among cholesterol reducing agents; Success of Warner-Lambert's statin, Lipitor; Novartis' Lescol.

  • Wyeth makes quality products available to all.  // Caribbean Business;2/26/2004, Vol. 32 Issue 8, pS23 

    Reports on the operation of Wyeth Consumer Healthcare in Puerto Rico. Leadership in the over-the-counter market; Quality of pharmaceuticals and healthcare products; Marketing campaign of the pharmaceutical company.

  • Alka-Seltzer's Speedy recovery. Lemonnier, Jonathan // Advertising Age;2/25/2008, Vol. 79 Issue 8, p6 

    The article reports that the pharmaceutical company Bayer is planning an advertising campaign in 2008 for its over-the-counter drug Alka-Seltzer that will feature Speedy Alka-Seltzer, the advertising mascot who was in the product's advertising from 1951-1964, and is considered a marketing icon....

  • OTC ad goal is first aid for image. DeNitto, Emily // Advertising Age;5/23/1994, Vol. 65 Issue 22, p8 

    Reports on the decision of Nonprescription Drug Manufacturers Association (NDMA) to run an advertising campaign to remedy the concern that healthcare reform is creating an uncaring, profit-hungry image of the industry in the United States. Total cost of the effort; Plan to run two eight-page...

  • After successful Rx-to-OTC switches, Claritin, Prilosec aim to sustain sales. Johnsen, Michael // Drug Store News;1/19/2004, Vol. 26 Issue 1, p35 

    Details the efforts of drug manufacturers to sustain the sales of Claritin and Prilosec in the U.S. Result of successful switch from prescription to nonprescription drugs; Competition from other nonprescription drugs; Opportunities for the introduction of other drugs in the market.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics